Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
2.11.2024 19:45:00 CET | ACCESS Newswire | Press release
European Investors Gain Unprecedented Entry to Leading Technology and Finance Pre-IPO Opportunities
LUXEMBOURG, LUXEMBOURG / ACCESSWIRE / November 2, 2024 / Holtway Global Hedge Pte. Ltd., a premier global wealth management firm with over €1 billion in assets under management, proudly announces its expansion into the European market. This strategic move provides European investors with unparalleled access to high-growth pre-IPO and IPO opportunities involving transformative sectors and notable assets like XRP, innovative technologies, and emerging leaders in space exploration, artificial intelligence, and blockchain development. Holtway Global Hedge is positioned to meet the growing demand for unique investment opportunities within Europe's dynamic financial markets.
"European investors are increasingly seeking access to high-potential pre-IPOs and IPOs," said Kian Tan, CEO of Holtway Global Hedge. "We're committed to offering them carefully vetted opportunities in transformative sectors such as blockchain, aerospace, and advanced technology. Our European expansion enables investors to participate in the growth of pre-IPO ventures led by renowned figures like Elon Musk, the visionary behind advanced space technologies and creator of products like Grok, and Sam Altman, known for pioneering innovations like ChatGPT."
Empowering Investors with High-Growth Potential Investments
Holtway Global Hedge's pre-IPO and IPO offerings allow European investors to invest in market-defining companies before they go public-an opportunity traditionally limited to institutional and U.S.-based investors. This includes access to companies involved with digital assets like XRP, and technologies shaping the future of finance, space exploration, and artificial intelligence.
Through a client-centric approach and comprehensive global market analysis, Holtway Global Hedge identifies opportunities in emerging industries, guiding investors through the complexities of pre-IPO and IPO investments. By focusing on innovative blockchain initiatives, pioneering space technology enterprises, and leaders in advanced sectors like AI and fintech, the firm connects clients with key players at the forefront of their respective industries.
Why Choose Holtway Global Hedge?
Exclusive Access: Gain entry to investment opportunities in high-demand sectors, including fintech, aerospace, artificial intelligence, blockchain, digital assets like XRP, and asset management.
Expert Insight: Leverage Holtway's extensive expertise, with over 40 financial advisors and partners collectively offering more than 250 years of wealth management experience.
Global Reach: Benefit from Holtway Global Hedge's international presence, supported by its headquarters in Singapore, a global operations office in Canada, and newly extended services across Europe.
About Holtway Global Hedge
Holtway Global Hedge is a global wealth management firm dedicated to empowering individuals and families to achieve financial freedom. With a focus on long-term growth, Holtway offers a diverse portfolio of wealth and investment services, specializing in access to pre-IPO and IPO markets worldwide.
Get Started with Holtway Global Hedge
For more information on pre-IPO and IPO opportunities, European investors are invited to visit HoltwayGlobal.com or contact our dedicated support team at info@holtwayglobal.com.
This release continues Holtway's legacy of offering exclusive investment options and emphasizes its growing presence in Europe, highlighting the firm's commitment to clients' financial success.
For further information on Holtway Global Hedge and its market insights, visit holtwayglobal.com or contact:
Media Contact:
Li Wei Tan
Director of Communications
Holtway Global Hedge
Email: media@holtwayglobal.com
Company Contact Information:
Holtway Global Hedge Pte. Ltd.
Phone: +65 3125 6069
Email: info@holtwayglobal.com
SOURCE: Holtway Global Hedge Pte. Ltd.
View the original press release on accesswire.com
Holtway Global Hedge Pte. Ltd.
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom